Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017)
Spero Therapeutics' (SPRO) quarterly Preferred Dividend Payments came in at $833000.0 in Q4 2017, down 9.26% YoY from $918000.0 in Q4 2016, and down 59.41% on a QoQ basis from $2.1 million in Q3 2017.
Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Spero Therapeutics (SPRO) has 2 years of Preferred Dividend Payments data on file, last reported at $833000.0 in Q4 2017.
- Quarterly Preferred Dividend Payments fell 9.26% year-over-year to $833000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $6.1 million (changed N/A YoY) and the FY2017 annual result came in at $6.1 million, up 78.61% from the prior year.
- Preferred Dividend Payments slipped to $833000.0 in Q4 2017, from $2.1 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.1 million in Q3 2017 to a low of $833000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 833,000.00 |
| Sep 30, 2017 | 2.05 Mn |
| Jun 30, 2017 | 2.03 Mn |
| Mar 31, 2017 | 1.24 Mn |
| Dec 31, 2016 | 918,000.00 |
| Sep 30, 2016 | 916,000.00 |